Doxorubicin
Back to searchMolecule Structure
Scientific Name
Doxorubicin
Description of the Drug
Doxorubicin is a medication used to treat various cancers, including AIDS-associated Kaposi’s Sarcoma and metastatic cancers.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00997
http://www.drugbank.ca/drugs/DB00997
Brand Name(s)
Adriblastina
Company Owner(s)
Actavis Inc, Amneal Eu Ltd, Hisun Pharmaceutical Hangzhou Co Ltd, Fresenius Kabi Usa Llc, Healthcare Pharmaceuticals Ltd, Baxter Healthcare Corp, Bristol Myers Squibb Co, Mylan Laboratories Ltd, Ayana Pharma Ltd, Sagent Pharmaceuticals Inc
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| DNA | NUCLEIC-ACID | INHIBITOR | CHEMBL2311221 |
| DNA topoisomerase II alpha | SINGLE PROTEIN | INHIBITOR | CHEMBL1806 |
Clinical Trial(s)
Unichem Links
| Atlas | doxorubicin | ||||||
| SureChEMBL | SCHEMBL3243 | ||||||
| PharmGKB | PA449412 | ||||||
| Human Metabolome Database | HMDB0015132 | ||||||
| DrugBank | DB00997 | ||||||
| PubChem: Thomson Pharma | 14910388 | 14910387 | |||||
| PubChem | 31703 | ||||||
| Mcule | MCULE-4188577717 | ||||||
| NMRShiftDB | 60023387 | ||||||
| LINCS | LSM-4062 | ||||||
| Nikkaji | J3.792C | ||||||
| PDBe | DM2 | ||||||
| BindingDB | 22984 | 32022 | |||||
| EPA CompTox Dashboard | DTXSID8021480 | ||||||
| LipidMaps | LMPK13050001 | ||||||
| DrugCentral | 960 | ||||||
| Metabolights | MTBLC28748 | ||||||
| Brenda | 127575 | 229405 | 32211 | 2134 | 229404 | 49017 | 832 |
| Guide to Pharmacology | 7069 | ||||||
| rxnorm | DOXORUBICIN | ADRIAMYCIN | DOXORUBICIN HYDROCHLORIDE | DOXIL | |||
| KEGG Ligand | C01661 | ||||||
| ChEBI | 28748 | ||||||
| ZINC | ZINC000003918087 |
